Lessons learnt from evidence-based approach of using Chinese herbal medicines in liver cancer

摘要: This paper is a systematic review of evidence-based studies the effectiveness Chinese herbal medicine (CHM) in treatment liver cancer. After detailed analysis literature, five animal and four human clinical trials met criteria for inclusion. Analysis revealed that results trials, whilst encouraging, need to be interpreted with caution as problems study designs may lead apparent benefits being attributable various forms bias. However, each CHM agents used these appeared potentially beneficial, further well-designed controlled randomized are warranted. The second part this focused on lessons learned from relationships between Traditional Medicine (TCM) theory, TCM Syndrome Differentiation, modern scientific understanding mechanisms action agents. Differentiation allow identification different patterns disharmony provide important guidance prescription CHM. Furthermore, quality control using both biological chemical fingerprinting ensure batch-to-batch consistency deliver sustained therapeutic benefit. Also, careful assessment herb-drug interactions paramount safety integrative use western chemotherapeutic